Citação norma APA

Han, S., Oza, A., Colombo, N., Raspagliesi, F., Wenham, R. M., & OAKNIN, A. (2023). A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer.

Citação norma Chicago

Han, Sileny, Amit Oza, Nicoletta Colombo, Francesco Raspagliesi, Robert M. Wenham, y ANA OAKNIN. A Randomized Phase 2 Study of Sapanisertib in Combination With Paclitaxel Versus Paclitaxel Alone in Women With Advanced, Recurrent, or Persistent Endometrial Cancer. 2023.

Citação norma MLA

Han, Sileny, et al. A Randomized Phase 2 Study of Sapanisertib in Combination With Paclitaxel Versus Paclitaxel Alone in Women With Advanced, Recurrent, or Persistent Endometrial Cancer. 2023.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.